Toxicological and Sensitization Studies of Novel Vascular Prostheses Made of Bacterial Nanocellulose Modified with Chitosan (MBC) for Application as the Tissue-Engineered Blood Vessels
Tóm tắt
Tissue-engineered blood vessels (TEBV) represent an attractive approach for overcoming reconstructive problems associated with vascular diseases in humankind by providing small caliber vascular grafts. The study evaluates biocompatibility and bioaffinity of vascular prostheses made from chitosan-modified bacterial cellulose (MBC) as potential scaffolds for TEBV. During the study, acute oral toxicity, up-and-down procedure (UDP), OECD test No. 425 on 10 Imp:WIST rats, intradermal reactivity on three Imp:BN albino rabbits, and sensitization on 15 Imp:DH guinea pigs were performed. The local effects were determined 1 month after intramuscular implantation of prostheses in 30 Imp:WIST rats. Histopathological and pathomorphological studies were conducted following complete removal of implants with peri-implant tissue. There were no signs of toxicity; the median lethal oral dose (LD50) was greater than 2 g/kg body weight for the rats. No allergic reactions were observed in the case of the guinea pig maximization test. Vascular grafts did not induce significant reactive changes in intradermal reactivity test (Main Irritation Index value 0.03) and do not induce inflammatory changes or hyperplasia of the muscle tissue surrounding the implant. Histopathological examination revealed ingrown vascular-connective bands. Tubes made of MBC offer strong potential for use in future TEBV programs for vascular surgery. Currently, the number of autologous grafts for coronary artery disease and for peripheral artery disease is limited. Particularly materials that will have contact with blood must comply with certain requirements such as mechanical strength, biocompatibility, and no potential to evoke adverse reactions. Bacterial nanocellulose modified with chitosan (MBC) due to its mechanical and biological properties is a promising material for replacing small-diameter vessels grafts. Although previous studies have not shown the toxicity of nanocellulose, we want to check whether medical products based on MBC will be safe when testing in vivo. Thirty Imp:WIST rats and 15 Imp:DH guinea pigs were subject of thorough analysis of potential toxicological and sensitization effect that may develop after applying vascular prostheses made from MBC to living organism. The analysis involved also histopathological and pathomorphological studies following complete removal of implants with peri-implant tissue. The results show that MBC prostheses do not cause any allergic, intradermal reactions and finally, do not display acute toxicity towards the organism in which it is implanted. Moreover, they had not induced inflammatory changes or hyperplasia of the muscle tissue surrounding the implantation sites, thus showing good biocompatibility. Obtained results were discussed with other available studies investigating various aspects of bacterial cellulose or modified bacterial cellulose influence on cells and tissues in both in vitro and in vivo studies. This is the first study analyzing the toxicological and sensitization effect which MBC may evoke and confirm the strong potential for use in future TEBV programs for vascular surgery.
Tài liệu tham khảo
de Oliveira Barud HG, da Silva RR, da Silva BH, Tercjak A, Gutierrez J, Lustri WR, et al. A multipurpose natural and renewable polymer in medical applications: bacterial cellulose. Carbohydr Polym. Elsevier Ltd. 2016;153:406–20.
Lustri WR, Barud HG d O, Barud H d S, Peres MFS, Gutierrez J, Tercjak A, et al. Microbial cellulose — biosynthesis mechanisms and medical applications. In: Cellulose - Fundamental Aspects and Current Trends: InTech; 2015.
Torres F, Commeaux S, Troncoso O. Biocompatibility of bacterial cellulose based biomaterials. J Funct Biomater. 2012 Dec;3(4):864–78.
Periayah MH, Halim AS, Saad AZM. Chitosan: a promising marine polysaccharide for biomedical research. Pharmacogn Rev. Medknow Publications. 2016;10:39–42.
Ciechańska D. Multifunctional bacterial cellulose/chitosan composite materials for medical applications. Fibres Text East Eur. 2004;12(4):69–72.
Lee SE, Park YS. The role of bacterial cellulose in artificial blood vessels. Molecul Cell Toxicol. Springer Verlag. 2017;13:257–61.
Wippermann J, Schumann D, Klemm D, Kosmehl H, Salehi-gelani S, Wahlers T. Preliminary results of small arterial substitute performed with a new cylindrical biomaterial composed of bacterial cellulose. Eur J Vasc Endovasc Surg [Internet]. 2009;37(5):592–6. Available from. https://doi.org/10.1016/j.ejvs.2009.01.007.
Scherner M, Reutter S, Klemm D, Sterner-Kock A, Guschlbauer M, Richter T, et al. In vivo application of tissue-engineered blood vessels of bacterial cellulose as small arterial substitutes: proof of concept? J Surg Res. 2014 Jun;189(2):340–7.
Lin N, Dufresne A. Nanocellulose in biomedicine: current status and future prospect. Eur Polym J. 2014;59:302–25.
Turbak AF, El-Kafrawy A, Snyder FW. AAB. Solv Syst Cellul. 1981;4:302,252.
Turbak AF. Newer cellulose solvent systems. In: Soltes EJ, editor. Wood and Agricultural Residues. New York: Academic Press; 1983. p. 87–99.
Magnusson B, Kligman AM. The identification of contact allergens by animal assay. The Guinea Pig Maximization Test. J Invest Dermatol [Internet]. 1968;52(3):268–76. Available from:. https://doi.org/10.1038/jid.1969.42.
Klemm D, Schumann D, Udhardt U, Marsch S. Bacterial synthesized cellulose — artificial blood vessels for microsurgery. Prog Polym Sci [Internet]. 2001;26(9):1561–603 Available from: http://www.sciencedirect.com/science/article/pii/S0079670001000211.
Weber C, Reinhardt S, Eghbalzadeh K, Wacker M, Guschlbauer M, Maul A, et al. Patency and in vivo compatibility of bacterial nanocellulose grafts as small-diameter vascular substitute. J Vasc Surg. 2018;68(6S):177S–187S.e1.
Hong F, Wei B, Chen L. Preliminary study on biosynthesis of bacterial nanocellulose tubes in a novel double-silicone-tube bioreactor for potential vascular prosthesis. Biomed Res Int. 2015;2015:1–9.
Aljebory A. Chitosan nanoparticles: review article Article in. Imp J Interdiscip Res. 2017.
Schumann DA, Wippermann ÆJ, Klemm ÆDO. Salehi-gelani TWÆS. Artificial vascular implants from bacterial cellulose: preliminary results of small arterial substitutes; 2009. p. 877–85.
Leitão AF, Faria MA, Faustino AMR, Moreira R, Mela P, Loureiro L, et al. A novel small-caliber bacterial cellulose vascular prosthesis: production, characterization, and preliminary in vivo testing. Macromol Biosci. 2016;16(1):139–50.
Azevedo EP, Retarekar R, Raghavan ML, Kumar V. Mechanical properties of cellulose: chitosan blends for potential use as a coronary artery bypass graft. J Biomater Sci Polym Ed. 2013;24(3):239–52.